Mr. Jason Birmingham reports

NOVERIS HEALTH SCIENCES ANNOUNCES COMMENCEMENT OF STRATEGIC REVIEW PROCESS

Noveris Health Sciences Inc.'s board of directors has commenced a strategic review process to evaluate the strategic and financial alternatives available to the company.

The board believes that a review of the company's strategic alternatives is appropriate in light of the company's current circumstances, including its financial position. As part of the strategic review, the board intends to consider a broad range of alternatives, including, without limitation, a merger or other business combination, a sale of all or part of the company or its assets, a going-private transaction, a recapitalization or other balance sheet initiative, strategic collaborations, licensing arrangements or partnerships, a capital raise, or the continued execution of the company's existing business plan as a public company.

The board is forming a special committee to assist with the strategic review.

Through the strategic review, the company is seeking to address its financial position and identify alternatives that may be available to it. The company's current cash resources are limited. If the company does not complete a transaction or obtain additional financing in the near term, the company may not have sufficient funds to continue its operations and development programs, and its business, financial condition and results of operations could be materially impaired. In light of prevailing market conditions, the company has elected not to proceed with the convertible debenture offering previously announced on Aug. 20, 2026. The company continues to evaluate and pursue other alternative financing opportunities.

There can be no assurances that the strategic review will result in any transaction or other outcome or, if a transaction is pursued, as to its terms, timing or completion.

About Noveris Health Sciences Inc.

Noveris is a Canadian life science company focused on opportunities in mental health and therapeutic innovation.

We seek Safe Harbor.